BAMS
Bellevue Asset Management (Switzerland) Portfolio holdings
AUM
$656M
This Quarter Return
-14.54%
1 Year Return
+11.48%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$613M
AUM Growth
+$613M
(-15%)
Cap. Flow
+$8.51M
Cap. Flow
% of AUM
1.39%
Top 10 Holdings %
Top 10 Hldgs %
30.19%
Holding
150
New
11
Increased
47
Reduced
31
Closed
17
Top Buys
| 1 |
Supernus Pharmaceuticals
SUPN
|
$4.49M |
| 2 |
Amgen
AMGN
|
$3.2M |
| 3 |
Larimar Therapeutics
LRMR
|
$3.2M |
| 4 |
INSY
Insys Therapeutics, Inc.
INSY
|
$2.56M |
| 5 |
Incyte
INCY
|
$2.21M |
Top Sells
| 1 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$6.46M |
| 2 |
Cardinal Health
CAH
|
$3.3M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
$3.09M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$2.98M |
| 5 |
Alkermes
ALKS
|
$2.96M |
Sector Composition
| 1 | Healthcare | 91.86% |
| 2 | Financials | 0.95% |
| 3 | Industrials | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
McKesson
MCK
$85.9B
| $7.59M | 1.24% |
41,000
| – | – |
|
27
Jazz Pharmaceuticals
JAZZ
$7.99B
| $7.44M | 1.21% |
56,000
| – | – |
|
28
Community Health Systems
CYH
$392M
| $6.94M | 1.13% |
196,431
+17,048
| +10% | +$603K |
|
29
BioMarin Pharmaceuticals
BMRN
$11.3B
| $6.85M | 1.12% |
65,000
| – | – |
|
|
KITE
30
DELISTED
Kite Pharma, Inc.
KITE
| $6.65M | 1.09% |
119,500
-55,500
| -32% | -$3.09M |
|
31
Boston Scientific
BSX
$159B
| $6.56M | 1.07% |
400,000
| – | – |
|
|
SHPG
32
DELISTED
Shire pic
SHPG
| $6.34M | 1.03% |
30,890
+3,090
| +11% | +$634K |
|
33
Edwards Lifesciences
EW
$47.7B
| $6.33M | 1.03% |
267,000
+62,400
| +30% | +$1.48M |
|
34
Perrigo
PRGO
$3.21B
| $6.29M | 1.03% |
40,000
| – | – |
|
35
Intuitive Surgical
ISRG
$158B
| $6.23M | 1.02% |
121,950
| – | – |
|
|
36
Cardinal Health
CAH
$36B
| $6.15M | 1% |
80,000
-43,000
| -35% | -$3.3M |
|
|
INSY
37
DELISTED
Insys Therapeutics, Inc.
INSY
| $5.98M | 0.97% |
210,000
+90,000
| +75% | +$2.56M |
|
|
AET
38
DELISTED
Aetna Inc
AET
| $5.8M | 0.95% |
53,000
+8,000
| +18% | +$875K |
|
39
Cencora
COR
$57.2B
| $5.7M | 0.93% |
60,000
| – | – |
|
40
Humana
HUM
$37.5B
| $5.37M | 0.88% |
30,000
+6,500
| +28% | +$1.16M |
|
41
Ionis Pharmaceuticals
IONS
$9.64B
| $5.34M | 0.87% |
132,000
+10,000
| +8% | +$404K |
|
42
CVS Health
CVS
$93B
| $5.31M | 0.87% |
55,000
+5,000
| +10% | +$482K |
|
|
MNK
43
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $5.12M | 0.83% |
80,000
+30,000
| +60% | +$1.92M |
|
|
CLVS
44
DELISTED
Clovis Oncology, Inc.
CLVS
| $5.06M | 0.83% |
55,000
-100
| -0.2% | -$9.2K |
|
|
XENT
45
DELISTED
Intersect ENT, Inc
XENT
| $4.68M | 0.76% |
199,777
+69,777
| +54% | +$1.63M |
|
46
Tenet Healthcare
THC
$16.5B
| $4.67M | 0.76% |
126,510
+4,560
| +4% | +$168K |
|
47
Johnson & Johnson
JNJ
$429B
| $4.67M | 0.76% |
50,000
| – | – |
|
48
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $4.61M | 0.75% |
230,000
-20,000
| -8% | -$401K |
|
|
BCR
49
DELISTED
CR Bard Inc.
BCR
| $4.57M | 0.74% |
24,500
-5,500
| -18% | -$1.02M |
|
|
50
Supernus Pharmaceuticals
SUPN
$2.52B
| $4.49M | 0.73% |
+320,000
| New | +$4.49M |
|